IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE MPO Test
Welcome to DNA Labs UAE, a leading genetic lab specializing in diagnostic tests. In this blog post, we will discuss the IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE MPO Test, its cost, symptoms, diagnosis, and other important details.
Test Details
The IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE (MPO) test is a diagnostic tool used to detect the presence of myeloperoxidase in tissue samples. Myeloperoxidase is an enzyme found in the granules of neutrophils, a type of white blood cell involved in the immune response.
The MPO test is commonly used in the field of pathology to identify and classify various types of leukemias and lymphomas. It helps determine the lineage of malignant cells and differentiate between myeloid and lymphoid neoplasms.
Test Components and Cost
The cost of the IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE MPO Test is AED 410.0.
Sample Condition and Submission
To perform the test, please submit tumor tissue in 10% Formal-saline or Formalin-fixed paraffin-embedded block. Ensure the sample is shipped at room temperature. Additionally, provide a copy of the Histopathology report, site of biopsy, and clinical history.
Report Delivery
The report for the IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE MPO Test will be delivered as follows:
- Sample: Daily by 6 pm
- Report Block: 5 days
- Tissue Biopsy: 5 days
- Tissue large complex: 7 days
Method and Test Type
The IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE MPO Test is performed using the immunohistochemistry method. It falls under the category of cancer tests.
Doctor and Test Department
The IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE MPO Test is typically requested by oncologists and pathologists. It is conducted in the test department of DNA Labs UAE.
Pre Test Information
Prior to the test, please provide a copy of the Histopathology report, site of biopsy, and clinical history. These details are essential for accurate diagnosis and interpretation of the test results.
Understanding the Test
During the IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE MPO Test, a tissue sample is obtained through a biopsy or surgical procedure. The sample is then processed and embedded in paraffin wax or frozen in a cryostat.
Thin sections of the tissue are placed on glass slides and treated with specific antibodies that bind to myeloperoxidase. These antibodies are usually labeled with a colored or fluorescent marker, allowing the visualization of the enzyme in the tissue under a microscope.
The presence of myeloperoxidase is indicated by the staining observed in the tissue sample. This information is crucial in confirming the diagnosis of certain leukemias and lymphomas, as well as monitoring the response to treatment.
Conclusion
The IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE MPO Test offered by DNA Labs UAE is a valuable tool in diagnosing and classifying leukemias and lymphomas. It provides important information for pathologists and helps determine the appropriate treatment plan for patients.
For more information or to schedule a test, please contact DNA Labs UAE today.
| Test Name | IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE MPO Test |
|---|---|
| Components | |
| Price | 410.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist, Pathologist |
| Test Department: | |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details | The immunohistochemistry myeloperoxidase (MPO) test is a diagnostic tool used to detect the presence of myeloperoxidase in tissue samples. Myeloperoxidase is an enzyme found in the granules of neutrophils, a type of white blood cell involved in the immune response. The MPO test is commonly used in the field of pathology to identify and classify various types of leukemias and lymphomas. It helps determine the lineage of malignant cells and differentiate between myeloid and lymphoid neoplasms. During the test, a tissue sample is obtained, typically through a biopsy or surgical procedure. The sample is then processed and embedded in paraffin wax or frozen in a cryostat. Thin sections of the tissue are placed on glass slides and treated with specific antibodies that bind to myeloperoxidase. The antibodies are usually labeled with a colored or fluorescent marker, allowing the visualization of the enzyme in the tissue under a microscope. The presence of myeloperoxidase is indicated by the presence of staining in the tissue sample. The immunohistochemistry MPO test is valuable in confirming the diagnosis of certain leukemias and lymphomas, as well as monitoring the response to treatment. It provides important information for the pathologist in determining the appropriate treatment plan for the patient. |
